ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1706

Quality of Life at Baseline in Early Psoriatic Arthritis Related to Disease Domains

Kim Wervers1, Jolanda J. Luime2, Ilja Tchetverikov3, Andreas H. Gerards4, Marc R. Kok5, Cathelijne W. Y. Appels6, Wiebo L. van der Graaff7, Hans L. M. van Groenendael8, Lindy-Anne Korswagen9, Jozien Veris10, Johanna M.W. Hazes11 and Marijn Vis2, 1Erasmus Medical Centre, Rotterdam, Netherlands, 2Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands, 3Albert Schweitzer Hospital, Dordrecht, Netherlands, 4Rheumatology, Vlietland Hospital, Schiedam, Netherlands, 5Maasstadweg 21, Maasstad Ziekenhuis, Rotterdam, Netherlands, 6Rheumatology, Amphia Hospital, Breda, Netherlands, 7Rheumatology, Rivas hospital, Gorinchem, Netherlands, 8Rheumatology, Reumazorg Zuid West Nederland, Roosendaal, Netherlands, 9Sint Franciscus Gasthuis, Rotterdam, Netherlands, 10Rheumatology, Reumazorg Zuid West Nederland, Goes, Netherlands, 11Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: psoriatic arthritis and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster II: Psoriatic Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Psoriatic arthritis (PsA) is a multifaceted disease. Affecting joints, skin, entheses and dactylitis, its impact on health-related quality-of-life (HRQoL) could be substantial. Up to now, the joints have been the main focus of treatment, while other disease facets were expected to improve along with DMARD treatment. Our aim is to describe HRQoL in newly diagnosed PsA patients taking into account swollen joints, tender entheses, dactylitis and the extent of skin involvement.

Methods: Baseline data of incident PsA patients was used from the Dutch south-west Psoriatic Arthritis Registry (DEPAR) study between August 2013 and March 2016. HRQoL was assessed by 8 subscales of the Short-Form 36 (SF-36) questionnaire (0-100, higher score represents a better HRQoL). Patients were classified in arthritis subtypes (i.e. mono-, oligo- or polyarthritis) by their rheumatologist.  Entheses were evaluated using the Leeds Enthesitis Index (LEI) and Maastricht Ankylosing Spondylitis Enthesitis Score (MASES; positive if tender entheses >1). Psoriasis was evaluated using the Psoriasis Area Severity Index (PASI; mild: 0-7; moderate/severe: >7) and dactylitis using the Leeds Dactylitis Index (LDI).

Results: 271 patients completed the SF-36 at baseline. Their average age was 50.4 years (SD 13.7) and 50% were male. 256 patients had arthritis: 62 had monoarthritis (M), 125 oligoarthritis (O) and 69 polyarthritis (P). Psoriasis was mild in 74% and moderate/severe in 13%. At least one digit with dactylitis was present in 12% of the patients. A tender enthesis was present in 47% of patients. Mean scores of the subdomains in the SF-36 were similar across the different arthritis-groups, with slightly worse scores for polyarthritis compared to mono- and oligoarthritis. However, when stratifying these groups for the presence of a tender enthesis, HRQoL decreased substantially for all groups across all subdomains of the SF-36, with a median difference of 14.3 points.  Irrespective of joint involvement, a tender enthesis (n=127) decreased the mean scores of all subdomains significantly compared to the non-tender enthesis group (n=144, p=0.0001). Severity of psoriasis and presence of dactylitis did not lead to significantly different SF-36 values compared to those not affected.

Conclusion: Having tender entheses impacts HRQoL severly in both its physical and mental dimensions in incident untreated PsA.


Disclosure: K. Wervers, None; J. J. Luime, None; I. Tchetverikov, None; A. H. Gerards, None; M. R. Kok, None; C. W. Y. Appels, None; W. L. van der Graaff, None; H. L. M. van Groenendael, None; L. A. Korswagen, None; J. Veris, None; J. M. W. Hazes, None; M. Vis, None.

To cite this abstract in AMA style:

Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael HLM, Korswagen LA, Veris J, Hazes JMW, Vis M. Quality of Life at Baseline in Early Psoriatic Arthritis Related to Disease Domains [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/quality-of-life-at-baseline-in-early-psoriatic-arthritis-related-to-disease-domains/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-of-life-at-baseline-in-early-psoriatic-arthritis-related-to-disease-domains/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology